PRNB - Principia Biopharma Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5848.7M
Enterprise Value 3693.91M
Trailing P/E N/A
Forward P/E 1-12.70
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)13.50
Price/Book (mrq)5.34
Enterprise Value/Revenue 311.04
Enterprise Value/EBITDA 6302.89

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 6.64%
Operating Margin (ttm)2.77%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)5.73%

Income Statement

Revenue (ttm)62.85M
Revenue Per Share (ttm)4.68
Quarterly Revenue Growth (yoy)-54.90%
Gross Profit (ttm)69.14M
Net Income Avi to Common (ttm)-8.77M
Diluted EPS (ttm)-0.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)163.62M
Total Cash Per Share (mrq)6.86
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.97
Book Value Per Share (mrq)6.66

Cash Flow Statement

Operating Cash Flow (ttm)-26.55M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 35.44%
52 Week High 338.34
52 Week Low 322.00
50-Day Moving Average 331.02
200-Day Moving Average 330.80

Share Statistics

Avg Vol (3 month) 3141.74k
Avg Vol (10 day) 3110.28k
Shares Outstanding 523.87M
Float 11.3M
% Held by Insiders 113.92%
% Held by Institutions 195.64%
Shares Short (May 31, 2019) 4584.04k
Short Ratio (May 31, 2019) 44.79
Short % of Float (May 31, 2019) 44.95%
Short % of Shares Outstanding (May 31, 2019) 42.45%
Shares Short (prior month Apr 30, 2019) 4394.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A